MARASTONI, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 10.325
AS - Asia 4.658
EU - Europa 2.235
SA - Sud America 710
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 84
OC - Oceania 16
Totale 18.136
Nazione #
US - Stati Uniti d'America 10.118
SG - Singapore 1.728
CN - Cina 1.224
BR - Brasile 554
UA - Ucraina 520
VN - Vietnam 463
HK - Hong Kong 415
DE - Germania 368
TR - Turchia 359
GB - Regno Unito 301
IT - Italia 212
PL - Polonia 163
FR - Francia 162
FI - Finlandia 151
SE - Svezia 126
RU - Federazione Russa 94
JP - Giappone 92
MX - Messico 84
IN - India 77
CA - Canada 74
BD - Bangladesh 57
AR - Argentina 47
ZA - Sudafrica 39
ID - Indonesia 38
BE - Belgio 34
CO - Colombia 34
IQ - Iraq 34
PK - Pakistan 27
NL - Olanda 26
ES - Italia 23
CL - Cile 21
EC - Ecuador 17
UZ - Uzbekistan 17
VE - Venezuela 16
MY - Malesia 15
AU - Australia 14
JM - Giamaica 13
PH - Filippine 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 10
IR - Iran 10
LT - Lituania 10
MA - Marocco 10
JO - Giordania 9
NP - Nepal 8
SV - El Salvador 8
UY - Uruguay 8
KR - Corea 7
RO - Romania 7
TN - Tunisia 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
PE - Perù 6
GT - Guatemala 5
KE - Kenya 5
OM - Oman 5
PY - Paraguay 5
TH - Thailandia 5
AT - Austria 4
CH - Svizzera 4
CR - Costa Rica 4
EG - Egitto 4
HN - Honduras 4
KG - Kirghizistan 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
EE - Estonia 3
IL - Israele 3
LB - Libano 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
LK - Sri Lanka 2
LY - Libia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GM - Gambi 1
GY - Guiana 1
HT - Haiti 1
Totale 18.014
Città #
Singapore 1.104
Ashburn 1.047
Woodbridge 897
Fairfield 876
San Jose 672
Houston 588
Jacksonville 568
Ann Arbor 502
Chandler 433
Santa Clara 427
Hong Kong 407
Beijing 400
Seattle 340
Wilmington 310
Dallas 309
Cambridge 252
Council Bluffs 247
Izmir 174
Nanjing 170
Ho Chi Minh City 163
Warsaw 158
Los Angeles 130
Dearborn 127
Hanoi 121
Princeton 107
San Diego 105
Lauterbourg 90
Tokyo 90
New York 87
Boardman 74
Addison 68
São Paulo 67
Milan 60
Mexico City 58
Munich 49
Shenyang 48
Hefei 46
Nanchang 44
Brooklyn 40
Shanghai 38
Ferrara 37
Chicago 36
Hebei 35
Brussels 34
Helsinki 30
Washington 30
Jiaxing 29
London 29
Phoenix 29
Da Nang 27
Tianjin 27
San Francisco 25
Buffalo 23
Jinan 23
San Mateo 23
Falkenstein 22
Toronto 22
Auburn Hills 21
Porto Alegre 21
Rio de Janeiro 21
Turku 21
Frankfurt am Main 20
Bremen 19
Changsha 19
Haiphong 19
Orem 19
Baghdad 18
Johannesburg 18
Kunming 18
Boston 16
Mountain View 16
Zhengzhou 16
Chennai 15
Jakarta 15
Montreal 15
Moscow 15
Stockholm 15
Manchester 14
Philadelphia 14
Atlanta 13
Poplar 13
Tashkent 13
Denver 12
Falls Church 12
Guangzhou 12
Norwalk 12
Bogotá 11
Columbus 11
Ningbo 11
Rome 11
Amsterdam 10
Belo Horizonte 10
Brasília 10
Dong Ket 10
Hải Dương 10
The Dalles 10
Des Moines 9
Indiana 9
Lahore 9
Redwood City 9
Totale 12.586
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 425
A cyclic peptide T analogue with high chemotactic activity 298
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 271
Arecoline tripeptide inhibitors of proteasome 264
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 253
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 236
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 233
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 233
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 226
Vinyl ester-based cyclic peptide proteasome inhibitors 224
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 224
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 222
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 216
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 215
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 215
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 214
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 213
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells 210
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 209
A 500 MHz study of peptide T in a DMSO solution 209
Opioid agonists and antagonists. Peptides containing N-terminal allyl groups and/or a thiomethylene linkage in place of a peptide bond 206
A Bioactive Fullerene Peptide 205
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 204
Conformational analysis of peptide T and of its C‐pentapeptide fragment 203
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 200
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 198
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 197
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 197
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 196
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 192
Synthesis, conformation and biological activity of dermorphin and deltorphin I analogues containing N-alkylglycine in place of residues in position 1, 3, 5 and 6 189
Structure–activity relationships of cyclic and linear peptide T analogues 186
Synthesis and opioid activity of partial retro‐inverso analogs of dermorphin 185
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 184
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 183
Anodic mineralization of pentachlorophenol in alkaline media 183
Amygdalin binds to the CD4 receptor as suggested from molecular modeling studies 182
Synthesis and biological activity of carboxyl terminally extended dermorphins 179
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 178
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 178
Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes 178
Conformational properties of deltorphin: new features of the delta-opioid receptors 172
Opioid deltorphin C analogues containing cis- or trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 171
Synthesis and Pharmacological Activity of Partially Modified Retro-Inverso Dermorphin Tetrapeptides 171
Trypanocidal activity of peptidyl vinyl ester derivatives selective for inhibition of mammalian proteasome trypsin-like activity 171
HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure 169
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 165
Glutamine vinyl ester proteasome inhibitors selective for trypsin-like (beta2) subunit 164
Reversed-phase HPLC study on the in vitro enzymic degradation of dermorphin 163
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 162
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors 162
Synthetic tetrapeptides related to dermorphin: Potent long lasting analgesic action following subcutaneous administration 162
Opioid peptides Synthesis and binding properties of dermorphin related heptapeptides 162
Synthesis and Opioid Activity of Dermorphin Tetrapeptides Bearing D-Methionine S-Oxide at Position 2 161
Ammino Acidi Conformazionalmente Vincolati: Sintesi di un Analogo della Metionina 161
New cyclic peptide proteasome inhibitors 160
Direct electro-oxidation of bisphenol-A in aqueous alkaline media 159
Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors 158
Synthesis and Opioid Activity of [sar4]dermorphin-Tetrapeptide Analogues 156
Peptide-based cationic liposomes and micelles as a new tool for nonviral gene delivery 153
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 153
Synthesis and structure activity relationships of delthorphine analogues 151
Synthesis and activity of dermorphine growth hormone releasing factor hybrid peptides 149
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogues 148
Peptide T-AraC Conjugates. Solid Phase Synthesis and Biological Activity of N4-(acylpeptidyl)-AraC 148
In vivo measurement of ANP overall turnover and identification of its main metabolic pathways under steady state conditions in humans 148
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope 147
analisi volumetricaper precipitazione, chelometria ed ossidoriduzione 145
Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit 141
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 141
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 140
Opioid peptides. Partially modified retro-inverso dermorphin analogues 140
Analisi volumetrica per precipitazione, chelometria ed ossidoriduzione 138
Preparation of mono-radioiodinated tracers for study of the in vivo metabolism of atrial natriuretic peptide in humans 137
Opioid peptides. Biological study of (D-Meto2) dermorphin analogues in relation to the plurality of opioid receptors 136
New features of the δ opioid receptor: Conformational properties of deltorphin I analogues 136
Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors 133
Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)-tartaric acid 132
Studies on the anti-phospholipase A2 and anti-inflammatory activities of a uteroglobin fragment and related peptides 130
Dehydro‐dermorphins: I. Influence of the stereo‐orientation of aromatic groups in dermorphin‐(1–5)‐peptides to opioid activity 130
Synthesis and biological activity of chelator-peptide T conjugates 127
Synthesis and activity of new linear and cyclic peptide T derivatives 127
Dehydro‐dermorphins: II. Synthesis and biological activity of unsaturated dermorphin hexa and heptapeptides 126
Identification of CD8+ T cell epitopes within lytic antigens of human herpes virus 8 125
Peptide-based molecules for the production of positive charged liposomes and micelles 123
Symmetry-based HIV protease inhibitors containing (S,S) or (R,R) tartaric acid core structure 122
New insights on μ/δ selectivity of opioid peptides: Conformational analysis of deltorphin analogues 121
Effects of peptide T derivatives on the proliferation of cultured human keratinocytes. 119
C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors 118
Structure-activity relationships of peptide T-related pentapeptides 117
Synthesis and biological activity of D-glucopyranosyl peptide T derivatives 114
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TO PENTAPEPTIDE ANALOG DERIVED FROM IMMUNODEFICIENCY VIRUS PROTEIN gp120 114
Studies of anti-phospholipase A2 and anti-inflammatory activites of a synthetic nonapeptide from uteroglobin 113
Structure-activity relationships of dermorphin tetrapeptides carrying a ketomethylene linkage 113
Opioid peptides. Synthesis and biological properties of dermorphin, related hexapeptides 108
null 107
Synthesis and antiaggregatory activity of antiflammin related peptides 107
null 107
Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides 103
Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies 97
Totale 17.046
Categoria #
all - tutte 80.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.367
Totale 81.877


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.132 0 0 77 89 110 43 55 75 47 81 86 469
2022/20231.009 121 41 31 123 176 165 41 89 132 5 49 36
2023/2024565 47 76 50 13 62 131 17 28 3 5 10 123
2024/20251.851 41 31 145 54 288 155 12 129 307 199 304 186
2025/20265.986 652 290 733 745 772 363 649 278 537 708 191 68
2026/2027865 193 315 357 0 0 0 0 0 0 0 0 0
Totale 18.136